Application of Cryopreserved Cord Blood in Treatment of Hypoferric Anemia of Pregnants
Keywords:hypoferric anemia of pregnants, â€œCryocell-Hemocordâ€ cord blood preparation
The method of complex therapy of hypoferric anemia (HFA) of pregnants in third trimester with application of â€œCryocell-Hemocordâ€ preparation of cord blood, together with standard medicamental treatment, has been suggested. It has been shown that application of â€œCryocell-Hemocordâ€ preparation enables to the correction of immunological damages, normalization of hematological indices and it is effective pathogenetic preparation of HFA treatment in pregnants.
How to Cite
Copyright (c) 2020 O. V. Ovchinnikova, I. A. Bondarenko, V. V. Lazurenko, O. V. Mertsalova, M. I. Antonyan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).